Stock CNTA CENTESSA PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News Centessa Pharmaceuticals plc

Equities

CNTA

US1523091007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
8.8 USD +4.14% Intraday chart for Centessa Pharmaceuticals plc +9.45% +10.55%
May. 31 Nxera Pharma to Receive $4.6 Million Milestone Payments From Centessa Pharmaceuticals MT
May. 13 Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Nxera Pharma to Receive $4.6 Million Milestone Payments From Centessa Pharmaceuticals
MT
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
AQ
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
Centessa Pharmaceuticals : 2023 UK Annual Report and Accounts
PU
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
GL
Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge
MT
Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS
MT
Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
GL
Centessa Pharmaceuticals Eyes $100 Million in ADS Offering
MT
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
GL
Centessa Pharmaceuticals Announces Open IND for ORX750, Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
AQ
Centessa Pharmaceutical Gets FDA's Approval to Begin Phase 1 Trial of Narcolepsy Drug Candidate
MT
Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
GL
Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
AQ
Centessa Pharmaceuticals plc Announces Open IND for ORX750
CI
Centessa Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Centessa Pharmaceuticals plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
GL
Centessa Pharmaceuticals Insider Sold Shares Worth $607,960, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CNTA Stock
  4. News Centessa Pharmaceuticals plc